Showing results (1-10 of 114) with videos related to
Sort By:
Pageof 12
Rinsho Shinkeigaku = Clinical Neurology|April 12, 2013
[Myotonic dystrophy-from pathomechanism as a RNA disease to future clinical trials]Masanori P TakahashiCurrent Opinion in Neurology|May 16, 2025
Update on the clinical and therapeutic aspects of myotonic dystrophy type 1Masanori P TakahashiBrain and Nerve = Shinkei Kenkyu No Shinpo|November 10, 2011
[Myotonic dystrophy: therapeutic approaches to RNA toxicity]Masayuki Nakamori, Masanori P TakahashiBrain and Nerve = Shinkei Kenkyu No Shinpo|January 28, 2017
[Myotonic Dystrophy: Advances in Translational Research]Masayuki Nakamori, Masanori P TakahashiJournal of Human Genetics|August 6, 2025
Molecular genetics of skeletal muscle channelopathiesTomoya Kubota, Masanori P TakahashiInternational Journal of Molecular Sciences|June 16, 2011
The role of α-dystrobrevin in striated muscleMasayuki Nakamori, Masanori P TakahashiRinsho Shinkeigaku = Clinical Neurology|December 19, 2014
[Therapeutic development in myotonic dystrophy]Masanori P Takahashi, Masayuki Nakamori, Hideki MochizukiRinsho Byori. the Japanese Journal of Clinical Pathology|May 8, 2014
[Myotonia and cardiac conduction defects in myotonic dystrophy and defect in ion channels]Tomoya Kubota, Masayuki Nakamori, Masanori P TakahashiEuropean Journal of Pharmacology|February 14, 2006
Class Ic antiarrhythmics block human skeletal muscle Na channel during myotonia-like stimulationFutoshi Aoike, Masanori P Takahashi, Saburo SakodaRinsho Shinkeigaku = Clinical Neurology|August 26, 2021
[Questionnaire surveys of clinical genetic specialists on the medical genetics for patients with myotonic dystrophy type 1]Tsuyoshi Matsumura, Yoshika Akizawa, Keiko Ishigaki, et al.Pageof 12